Vaccination versus SARS-CoV-2 Omicron: three vaccine doses win the battle.

Popowicz GM, Pyrc K, Hadian K.

Open source

DOI: 10.1038/s41392-022-01000-3
Published: 2022-04-27
Container: Signal Transduct Target Ther
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41392-022-01000-3,
  title = {Vaccination versus SARS-CoV-2 Omicron: three vaccine doses win the battle.},
  author = {Popowicz GM and  Pyrc K and  Hadian K.},
  year = {2022},
  journal = {Signal Transduct Target Ther},
  doi = {10.1038/s41392-022-01000-3},
  url = {https://doi.org/10.1038/s41392-022-01000-3}
}

RIS

TY  - JOUR
TI  - Vaccination versus SARS-CoV-2 Omicron: three vaccine doses win the battle.
AU  - Popowicz GM
AU  -  Pyrc K
AU  -  Hadian K.
PY  - 2022
JO  - Signal Transduct Target Ther
DO  - 10.1038/s41392-022-01000-3
UR  - https://doi.org/10.1038/s41392-022-01000-3
ER  -

APA

GM, P., K, P., & K., H. (2022). Vaccination versus SARS-CoV-2 Omicron: three vaccine doses win the battle.. Signal Transduct Target Ther. https://doi.org/10.1038/s41392-022-01000-3

Source records

europe-pmc · retrieved 2026-09-26T22:12:14.258Z
doaj · retrieved 2026-09-26T22:12:14.256Z